Glucerna in a Hospital Setting Beneficial to Type 2 Patients
In hospitalized people with type 2 diabetes, Glucerna was found to have a “neutral effect on [blood glucose] control and lipid metabolism . . . compared with a high-carbohydrate and a lower-fat formula.”
A research group from Madrid, Spain, compared blood glucose and lipid control in 63 hospitalized patients with type 2 diabetes requiring feeding via nasogastric tube. For an average of 13 days, the patients received a diet that was low in carbohydrate and high in monounsaturated fat (Glucerna) or a high-carbohydrate diet (Precitene Diabet).
“Mean glucose was significantly increased at seven days of treatment in the Precitene arm,” write the researchers, “with no significant variations in the Glucerna arm.”
In addition, average weekly blood triglyceride levels in the Precitene group were increased without reaching statistical significance, whereas patients in the Glucerna group showed a stable trend.
—Journal of Parenteral and Enteral Nutrition, January–February 2005Click Here To View Or Post Comments